SINGAPORE and SAN DIEGO – April 14, 2021 – ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, today announced it has completed a $14 million fundraising round led by existing investors...
ImmunoScape has continued its COVID-19 collaboration with NIAID and the Johns Hopkins University to better understand if the CD8+ T-cell responses from COVID-19 recovered individuals still recognize the major SARS-CoV-2 variants. Out of 45 mutations assessed from the...
Helsinki, Finland, 9 March 2021: Valo Therapeutics Limited (Valo Tx), the developer of novel and adaptable immunotherapy platforms for cancer and infectious diseases, today announced the completion of a successful collaboration with the biotechnology company...
Geoff Nosrati, Ph.D., ImmunoScape’s Chief Business Officer, will be presenting on, “Advancing the development of next-generation therapeutics with the Deep Immunomics platform.” at Biocom’s upcoming Global Life Science Partnering Conference....
SINGAPORE and SAN DIEGO – January 28, 2021 – ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, today announced the formation of its Scientific Advisory Board (SAB). The SAB is...
